Evoke Pharma Granted FDA Market Exclusivity for GIMOTI®

By
lbeveridge
-
0
285
Evoke Pharma, Inc. announced that it has been granted new drug product exclusivity by the US FDA for GIMOTI (metoclopramide) nasal spray.
[Evoke Pharma, Inc.]
Press Release